HWKN Hawkins Earnings and EPS analysis

  1. Stocks
  2. Basic Materials
  3. NASDAQ: HWKN
  4. Earnings
?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 55
Relative Valuation: Rel. Valuation: 33
Relative Profitability: Rel. Profitability: 57

EPS in 2026 (TTM): $3.93

Last Report Period Date: Mar 29, 2026

As of June 2026, according to Hawkins's latest financial report, the company's current EPS (TTM) is $3.93. Hawkins's EPS for 2026 came in at $3.93, marking a decrease from $4.05 in 2025. Hawkins's earnings per share for the quarterly report ending on Mar 29, 2026 was $0.74.

HWKN earnings history

Historical annual and quarterly earnings per share (EPS) data for Hawkins
EPS (TTM)
$3.93
EPS Growth YoY (Quarterly)
-5.1%
EPS (Quarterly)
$0.74
EPS Growth (Quarterly)
7.2%

The annual EPS in 2026 was $3.93, a decrease of 3% from $4.05 in 2025. The quarterly EPS for the period ending Mar 29, 2026, was $0.74, marking a 5.1% decrease from the same quarter last year. HWKN's TTM EPS stands at $3.93 as of March 2026. Hawkins's EPS for 2025 stood at $4.05, a 12.2% increase from 2024.

HWKN earnings chart

HWKN EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-5.1%
EPS growth YoY
-3%
EPS growth 3Y avg
10.9%
EPS growth 5Y avg
15%

Hawkins has recorded a decrease in EPS of 5.1% over the last 12 months (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of 10.9% per year over the past 3 years. Hawkins had an average annual EPS growth rate of 15% over the last 5 years. A 10-year view shows that HWKN has seen an average EPS growth of 16.4% per year.

HWKN Earnings Waterfall

Breakdown of revenue, profit and net income for Hawkins

HWKN Earnings vs Peers

What are the earnings of HWKN compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
HWKN Hawkins Inc 41.57 -3% 10.9% 15%
KWR Quaker Chemical Corp 523.25 -102.2% N/A N/A
ALB Albemarle Corp N/A 48.6% N/A N/A
FMC Fmc Corp N/A -754.9% N/A N/A
ACET Adicet Bio Inc N/A 20.5% N/A N/A
AVD American Vanguard Corp N/A 61.1% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.